# Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection

> **NCT06701838** · — · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 15 (estimated)

## Conditions studied

- Cushing's Disease
- Hypercortisolism
- Pituitary Adenoma
- Pituitary ACTH Secreting Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** 11C-Methionine PET/CT

## Key facts

- **NCT ID:** NCT06701838
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-03
- **Primary completion:** 2026-07-05
- **Final completion:** 2026-07-05
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701838, "Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06701838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*